Denis Chem Lab

Denis Chem Lab ROE

The Return on Equity (ROE) of Denis Chem Lab (537536.BO) as of Oct 21, 2026 is 9.18 %. In the previous year, Return on Equity (ROE) was 9.49 % — a change of -3.23% (lower).

ROE

9.18 %

YoY

-3.23%

Last updated:

In 2025, Denis Chem Lab's return on equity (ROE) was 9.18 %, a -3.23% increase from the 9.49 % ROE in the previous year.

The Denis Chem Lab ROE history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

ROE
Date
ROE
Jan 1, 2018
11.25 INR
Jan 1, 2019
7.13 INR
Jan 1, 2020
3.68 INR
Jan 1, 2021
9.42 INR
Jan 1, 2022
10.88 INR
Jan 1, 2023
13.88 INR
Jan 1, 2024
9.49 INR
Jan 1, 2025
9.18 INR
The Denis Chem Lab ROE history
YEARROEYoY
9.18 %-3.23%
9.49 %-31.64%
13.88 %+27.62%
10.88 %+15.40%
9.42 %+156.00%
3.68 %-48.38%
7.13 %-36.59%
11.25 %+161.96%
4.29 %+3.58%
4.14 %-115.35%
-27.01 %-304.38%
13.21 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Denis Chem Lab Stock analysis

What does Denis Chem Lab do? Denis Chem Lab Ltd. generates revenue through the manufacture and sale of transfusion solutions in bottles, including sterile intravenous injectables for human and veterinary use. The company offers a range of products such as carbohydrate solutions, sodium chloride solutions, potassium chloride solutions, and plasma volume expanders under its own brands. It also produces sterile intravenous injectables in volumes from 100 milliliters to 10 liters for direct sales to customers. Additionally, the firm manufactures contract products for multinational pharmaceutical companies, leveraging its facility for third-party production. The company's primary customers include healthcare providers and veterinary institutions that require sterile intravenous solutions. Its product portfolio targets both human and veterinary markets, with offerings like antibiotic solutions and dialysis solutions catering to specific medical needs. The firm's contract manufacturing services provide an additional revenue stream by supplying multinational pharmaceutical companies with custom-produced sterile injectables. Denis Chem Lab Ltd. focuses on manufacturing and selling its own branded products, such as carbohydrate in sodium chloride solutions and multi electrolyte solutions, while also engaging in contract manufacturing for multinational pharmaceutical companies. The company's production capabilities span from small-volume solutions to large 10-liter bottles, ensuring versatility in meeting diverse customer demands across healthcare and veterinary sectors. Denis Chem Lab is one of the most popular companies on Eulerpool.

ROE Details

Decoding Denis Chem Lab's Return on Equity (ROE)

Denis Chem Lab's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.

Year-to-Year Comparison

Analyzing Denis Chem Lab's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.

Impact on Investments

Denis Chem Lab's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.

Interpreting ROE Fluctuations

Changes in Denis Chem Lab’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.

Frequently Asked Questions about Denis Chem Lab stock

Return on Equity (ROE) of Denis Chem Lab is 9.18 % in 2025.

Return on Equity (ROE) of Denis Chem Lab changed from 9.49 % to 9.18 %, representing a -3.23% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Return on Equity (ROE) Denis Chem Lab since 2006 – with annual values, charts, and detailed analysis.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Equity (ROE)'s Denis Chem Lab with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Equity (ROE)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Equity (ROE).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Profitability — Denis Chem Lab

ROEROAROCEROICAsset TurnoverInventory TurnoverReceivables TurnoverDays Sales OutstandingDays Inventory OutstandingDays Payable OutstandingCash Conversion CycleCROICGross Profit/AssetsFixed Asset TurnoverEquity TurnoverWorking Capital TurnoverPayables TurnoverCapital IntensityReceivables/RevenueInventory/RevenueEBIT/Assets

All Key Metrics — Denis Chem Lab